Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASTRAZENECA

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 31
  • 0 comments

FDA approve ALBUTEROL SULFATE; BUDESONIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 16, 2025, 04:09 UTC
  • 38
  • 0 comments

FDA approve POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Comment Full text

CORSTASIS THERAPEUTICS

  • FDA Approval
  • Sept. 15, 2025, 18:57 UTC
  • 36
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 36
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 29
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 37
  • 0 comments

FDA approve TERBINAFINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Sept. 12, 2025, 08:43 UTC
  • 32
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

COVIS

  • FDA Approval
  • Sept. 12, 2025, 08:43 UTC
  • 31
  • 0 comments

FDA approve RILUZOLE

Comment Full text

AMNEAL

  • FDA Approval
  • Sept. 12, 2025, 08:43 UTC
  • 44
  • 0 comments

FDA approve SODIUM OXYBATE

Comment Full text

ITALFARMACO SA

  • FDA Approval
  • Sept. 12, 2025, 08:43 UTC
  • 33
  • 0 comments

FDA approve RILUZOLE

Comment Full text
  • Previous
  • 41
  • 42
  • 43
  • 44
  • 45
  • Next

Search

News categories

  • Technical Exchange News(10587)
  • Event(1974)
  • SEC News(184241)
  • FDA Approval(9830)
  • Company Report(721)
  • Business News(122112)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin